

MCQOPTIONS
Saved Bookmarks
1. |
In October 2020, which of the following has received the Securities and Exchange Board of India’s approval to go ahead with its proposed ₹6,000 crore IPO? |
A. | Gland Pharma Ltd |
B. | Aurobindo Pharma |
C. | Sms Pharmaceuticals |
D. | Intas Biopharmaceuticals |
E. | Mankind Pharma |
Answer» B. Aurobindo Pharma | |